title: A meta-analysis of salicylates for type 2 diabetes mellitus.
abstract: The aim of this study was to assess the effects and safety of salicylates on type 2 diabetes mellitus (T2DM). We searched six databases (Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CBM, CNKI and VIP) for all randomized controlled trials (RCTs) and self-control studies which investigated the effects of salicylates on T2DM. We included 34 RCTs and 17 self-control studies involving 13 464 patients with T2DM. It was demonstrated that salicylates had obvious effects on several parameters for patients with T2DM. (1) Any dose of salicylates could significantly reduce HbA1c level [mean difference (MD) -0.39%; 95% CI -0.47 to -0.32] in RCTs, but only high doses of salicylates (≥3000 mg/day) could effectively reduce fasting plasma glucose (FPG) level [standardized mean difference (SMD) -1.05; 95% CI -1.47 to -0.62] for patients with T2DM in both RCTs and self-control studies. Furthermore, high doses of salicylates could also increase plasma fasting insulin level (MD 12.20 mU/L; 95% CI 3.33 to 21.07); (2) In both RCTs and self-control studies, high doses of salicylates could significantly reduce plasma triglycerides concentration. The results for RCTs were MD -0.44 mmol/L, 95% CI -0.71 to -0.18, and those for self-control studies were 227±29 mg/dL (pre-treatment) and 117±8 mg/dL (post-treatment) (P=0.009); (3) All trials which reported cardiovascular events were RCTs using low doses (<1000 mg/day) of salicylates, and it was revealed that aspirin could significantly reduce the risk of myocardial infarction (OR 0.73; 95% CI 0.57 to 0.92); (4) Two RCTs and two self-control studies with ≥3000 mg/day salicylates reported adverse effects, and the overall effects were mild, and tinnitus occurred most frequently. No evidence of gastrointestinal bleeding was found in all these studies. In conclusion, from our systematic review, the anti-diabetic effect of salicylates is in a dose-dependent manner. High doses of salicylates may have beneficial effects on reducing FPG, HbA1c level and increasing fasting insulin concentration, and may also have some positive effects on lipidemia and inflammation-associated parameters for patients with T2DM, without serious adverse effects.
authors: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors: Fang
authors: F
authors: Fang
authors: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors: Yu
authors: Y
authors: Lu
authors: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors: De-Lin
authors: DL
authors: Ma
authors: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors: Ting-Ting
authors: TT
authors: Du
authors: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
authors: Shi-Ying
authors: SY
authors: Shao
authors: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. xfyu188@163.com.
authors: Xue-Feng
authors: XF
authors: Yu
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000401:mortality* / Q000517:prevention & control*; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D015994:Incidence; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D012307:Risk Factors; D012459:Salicylates / Q000627:therapeutic use*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D012459:Salicylates
references: J Am Coll Cardiol. 2010 Jun 22;55(25):2878-86
references: 20579547
references: Nephrol Dial Transplant. 2003 Mar;18(3):539-42
references: 12584276
references: Arch Ophthalmol. 1992 Mar;110(3):339-42
references: 1543449
references: Br Med J. 1901 Mar 30;1(2100):760-2
references: 20759517
references: Diabetes. 1994 Nov;43(11):1271-8
references: 7926300
references: Diabetes. 1978 Jul;27(7):750-6
references: 658622
references: Science. 1994 Aug 12;265(5174):956-9
references: 8052854
references: Science. 2001 Aug 31;293(5535):1673-7
references: 11533494
references: Acta Endocrinol Suppl (Copenh). 1980;239:6-8
references: 7001843
references: Ann Pharmacother. 2010 Jul-Aug;44(7-8):1207-21
references: 20516365
references: Nat New Biol. 1971 Jun 23;231(25):232-5
references: 5284360
references: J Clin Invest. 2002 May;109(10):1321-6
references: 12021247
references: Clin Endocrinol (Oxf). 1984 Dec;21(6):649-55
references: 6391745
references: Thromb Haemost. 1985 Dec 17;54(4):895
references: 3911483
references: Am J Med Sci. 1963 Apr;245:456-8
references: 13947866
references: Lancet. 1980 Feb 23;1(8165):394-6
references: 6101847
references: J Biol Chem. 1993 Dec 15;268(35):26055-8
references: 8253716
references: Arch Ophthalmol. 1995 Jan;113(1):52-5
references: 7826294
references: J Clin Invest. 1977 Sep;60(3):747-53
references: 330566
references: Diabetes. 1989 Apr;38(4):491-8
references: 2647556
references: Exp Clin Endocrinol. 1988 Sep;92(1):119-22
references: 3229444
references: Diabetes Care. 2008 Feb;31(2):289-94
references: 17959861
references: Br Med J. 1957 Nov 9;2(5053):1071-4
references: 13472052
references: Scand J Urol Nephrol. 2002;36(2):145-8
references: 12028688
references: J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S3-9
references: 19801365
references: Lancet. 1967 Jun 3;1(7501):1191-4
references: 4165134
references: Lancet. 1998 Jun 13;351(9118):1755-62
references: 9635947
references: Metabolism. 1959 Jul 1;8(4 Pt 1):418-28
references: 13666386
references: Lancet. 1959 Dec 12;2(7111):1067
references: 13821819
references: Nature. 1998 Nov 5;396(6706):77-80
references: 9817203
references: Control Clin Trials. 1996 Feb;17(1):1-12
references: 8721797
references: Thromb Res. 2000 Feb 15;97(4):239-45
references: 10674411
references: Diabetologia. 1985 Sep;28(9):671-6
references: 3905478
references: Ann Intern Med. 2010 Mar 16;152(6):346-57
references: 20231565
references: J Mol Med (Berl). 2002 Oct;80(10):618; discussion 619
references: 12530411
references: Diabetes Care. 2007 Jul;30(7):e66
references: 17596489
references: Diabetes Obes Metab. 2008 Aug;10(8):668-74
references: 18034847
references: Circulation. 2000 Oct 24;102(17):2022-3
references: 11044413
references: Med Hypotheses. 2010 Sep;75(3):276-81
references: 20080359
references: Ophthalmology. 1991 May;98(5 Suppl):757-65
references: 2062511
references: Clin Transl Sci. 2008 May;1(1):36-43
references: 19337387
references: JAMA. 2008 Nov 12;300(18):2134-41
references: 18997198
references: Metabolism. 1981 Mar;30(3):293-8
references: 7010074
references: N Engl J Med. 2005 Mar 31;352(13):1293-304
references: 15753114
references: Diabetes Care. 1997 May;20(5):832-5
references: 9135951
references: Science. 1993 Jan 1;259(5091):87-91
references: 7678183
references: Diabet Med. 1997 May;14(5):405-6
references: 9171260
references: Metabolism. 1981 Nov;30(11):1065-75
references: 7026970
references: BMJ. 2008 Oct 16;337:a1840
references: 18927173
references: Clin Chim Acta. 2008 May;391(1-2):120-2
references: 18314008
references: West J Med. 1983 Jul;139(1):46-9
references: 6624082
references: J Clin Invest. 2006 Jul;116(7):1793-801
references: 16823477
references: N Engl J Med. 1989 Jul 20;321(3):129-35
references: 2664509
references: Lancet. 1964 Dec 5;2(7371):1205-7
references: 14215560
references: Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1205-11
references: 19755670
references: Diabetes Care. 2003 Dec;26(12):3264-72
references: 14633812
references: Diabetologia. 2009 Mar;52(3):385-93
references: 19104769
references: Diabetes Care. 2004 Jan;27 Suppl 1:S72-3
references: 14693931
references: J Immunol. 1996 May 15;156(10):3961-9
references: 8621937
references: Diabetes. 1978 Dec;27(12):1196-1204
references: 720774
references: J Atheroscler Res. 1968 Jul-Aug;8(4):705-19
references: 5679952
references: Circulation. 2009 Mar 10;119(9):1284-92
references: 19237660
references: JAMA. 1992 Sep 9;268(10):1292-300
references: 1507375
references: Clin Endocrinol (Oxf). 1983 Jun;18(6):613-9
references: 6349864